Literature DB >> 25075012

Intratumoral lymphangiogenesis and prognostic significance of VEGFC expression in gastric cancer.

Keisuke Ikeda1, Eiji Oki2, Hiroshi Saeki1, Koji Ando1, Masaru Morita1, Yoshinao Oda3, Masakazu Imamura1, Yoshihiro Kakeji1, Yoshihiko Maehara1.   

Abstract

AIM: Vascular endothelial growth factor C (VEGFC) is thought to promote lymphangiogenesis in various human cancer tissues.
MATERIALS AND METHODS: The present study analyzed data from 72 patients with gastric cancer. The lymphatic vessel density (LVD) was determined by immunohistochemical staining using a monoclonal antibody (mAb) against D2-40, and the expression of VEGFC was investigated using a mAb against VEGFC.
RESULTS: The intratumoral LVD was higher in cases with nodal metastasis. The VEGFC-positive cases had a higher intratumoral LVD and were more invasive to the lymphatic vessels or lymph nodes than negative cases. Patients with VEGFC-positive cancer had significantly lower survival than those with negative cancer (p<0.05).
CONCLUSION: The expression of VEGFC was related to intratumoral lymph angiogenesis and serves as a pertinent predictive factor for lymphatic invasion or metastasis, while also providing prognostic value. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  VEGFC; gastric cancer; lymph node metastasis; lymphangiogenesis; lymphatic vessel density

Mesh:

Substances:

Year:  2014        PMID: 25075012

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  A meta-analysis of the lymphatic microvessel density and survival in gastric cancer with 1809 cases.

Authors:  Liang Liang; Wen-Ting Huang; Rong-Quan He; Hai-Wei Liang; Chun-Qin Huang; Hong Zhou; Fang-Lin Wei; Sheng-Sheng Zhou; Zhi-Gang Peng; Gang Chen; Jun-Qiang Chen; Xin-Gan Qin
Journal:  Oncotarget       Date:  2017-12-21

2.  Somatic mutations and increased lymphangiogenesis observed in a rare case of intramucosal gastric carcinoma with lymph node metastasis.

Authors:  Naoki Ikari; Shota Aoyama; Akiyoshi Seshimo; Yuji Suehiro; Tomoko Motohashi; Shohei Mitani; Sawako Yoshina; Etsuko Tanji; Akiko Serizawa; Takuji Yamada; Kiyoaki Taniguchi; Masakazu Yamamoto; Toru Furukawa
Journal:  Oncotarget       Date:  2018-01-22

3.  HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells

Authors:  Yarely M Salinas-Vera; Dolores Gallardo-Rincón; Raúl García-Vázquez; Olga N Hernández-de la Cruz; Laurence A Marchat; Juan Antonio González-Barrios; Erika Ruíz-García; Carlos Vázquez-Calzada; Estefanía Contreras-Sanzón; Martha Resendiz-Hernández; Horacio Astudillo-de la Vega; José L Cruz-Colin; Alma D Campos-Parra; César López-Camarillo
Journal:  Front Oncol       Date:  2019-05-14       Impact factor: 6.244

4.  A predictive model for assessing prognostic risks in gastric cancer patients using gene expression and methylation data.

Authors:  Dan Luo; QingLing Yang; HaiBo Wang; Mao Tan; YanLei Zou; Jian Liu
Journal:  BMC Med Genomics       Date:  2021-01-06       Impact factor: 3.063

5.  Steroid receptor coactivator-1 interacts with NF-κB to increase VEGFC levels in human thyroid cancer.

Authors:  Bo Gao; Lingji Guo; Donglin Luo; Yan Jiang; Jianjie Zhao; Chengyi Mao; Yan Xu
Journal:  Biosci Rep       Date:  2018-06-12       Impact factor: 3.840

6.  Clinical importance of VEGFC and PD-L1 co-expression in lung adenocarcinoma patients.

Authors:  Tingting Qin; Junling Xia; Shaochuan Liu; Jing Wang; Hailin Liu; Yan Zhang; Yanan Jia; Kai Li
Journal:  Thorac Cancer       Date:  2020-03-10       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.